HomeKurzfassungUrsachenTherapieAnmerkungenImpressum u. HaftungKontaktPraxisumzugPraxisbesuchSelbstbehandler
In EnglishChancesSubstancescostsIrradiationRemarksQuestionnaireIntern

On this page “Remarks”, you will find two chapters: 

Chapter A: In which the way or form does the repigmentation appear if a patient reacts positively with the treatment? How do we avoid a relapse of vitiligo after a successful treatment?

Chapter B: Some remarks about orthomolecular medicine, which is the main objective of treatment in our clinic.

Chapter A: 

In which way or form does the repigmentation appear if a patient reacts positively with the treatment? How do we avoid a relapse of vitiligo after a successful treatment?

Even with our complex treatment program for vitiligo we only observe a slow onset of repigmentation.  We have to expect a time period of four to six months before we can definitely evaluate our treatment as positive in the result or as a failure.

 Sometimes patients respond with repigmentation obviously already after six weeks or two months, some others only after four or five months. In order to ensure that we do not miss a possible repigmentation of a given patient, we decide on a positive or negative response to the treatment only after six months of permanent treatment.

Any pigmentation starts in the same way as with any other successful treatment of vitiligo: with the appearance of small dots of pigments which may spread all over the former completely white areas and some times later by forming small islands of pigmentation which may connect to each other in the form of bigger islands and then continents of pigmentation before, hopefully, the formerly white areas will be completely repigmentated.

If after six months of treatment we come to the conclusion that our treatment is successful because we can at least observe some percentage of repigmentation, a continuation of the treatment will be useful and we can expect that the pigmentation will continue with time.

If after six months there’s no response to our treatment in that sense, we may decide to ad some other supplements to the treatment or to conclude that the treatment is not useful for a given patient.

 If we continue our treatment because of a positive response, it may happen after some months, that the formation of new pigments stops for unknown reasons, before a complete or at least a satisfying result of repigmentation.

In such a case we would stop the treatment, or at least the irradiation therapy, for a month or two. Quite often the regimentation starts again after such a break.

At the end of our treatment, that means after a full repigmentation or at least a satisfying result, if 100% repigmentation cannot be achieved, we have to decide on what to do in order to avoid another onset of  depigmentation months or years later.

If vitiligo is successfully treated with our method: can we say that vitiligo is definitely "healed"? 

 The answer reads: no! Vitiligo can only be treated successfully in its visible manifestation (those white areas on the skin will disappear!). This is great, isn’t it! But these white areas (or different areas compared to those affected before) m a y reappear sooner or later (years or decades later). This is because we cannot (yet) change the genetic determination of vitiligo in our chromosomes. The possibility of reappearance of white areas remains. But then again we will be able to treat those white areas, so that they may disappear again (for years or decades hopefully!). We also have a chance to avoid the reappearance of white areas after a successful treatment by continuing to take those supplements that we use for the acute treatment of, but in lower dose (half dose or less compared the actual acute treatment course).

Why do we believe, that a continuation of our oral supplementation program could possibly avoid a relapse of vitiligo?

My observation is, that many patients who have undergone UV- irradiation treatment alone (with nor medication) before, without any success, react positively to our treatment which also includes UV-irradiation, but in difference to UV-irradiation alone, also includes our oral supplement program.

Out of this observation we can conclude, that our supplement program, which is containing just nutrients, but in a higher concentration compared to food, must have been in short in the patient’s metabolic system before. In other words, we have treated a shortage of nutrients, which among other factors, may have contributed to the patient’s vitiligo.

Does this explanation have some logic for you? 

In case you agree, you may also agree, that we can possibly expect to avoid a future new onset of vitiligo (relapse), by continuing the same supplementation used for the treatment, but in the lower dose.

This is what I suggest to do after a successful treatment with our program.

I cannot prove that the continuation of this supplementation will definitely avoid the relapse of vitiligo in future, because our experience with this treatment program for vitiligo is only seven years until today. So we cannot say anything about a lifelong period of vitiligo condition and to which degree we can avoid the recurrence he of vitiligo throughout a patient’s lifespan

On the other hand, this type of supplementation is not only harmless for our patients but also beneficial for general health (as mentioned before regarding side-effects of our treatment; please refer to “English”, Chapter A) especially as we will reduce the dose for prevention to half or less compared to the acute treatment dose.

Under these aspects the continuation of a lower dose supplementation is not a risk for health’s but only a financial one.

 Presently I leave it to my patients whether they want to continue the oral supplementation treatment as prevention for a vitiligo relapse, as I cannot promise anything for the reasons explained before. The theory that I’ve mentioned before, must be practically proven in future. Maybe you can prove it for yourself.

Of course patients can stop their treatment completely, when they are satisfied with the result and wait for what will happen in the future. If their vitiligo reoccurs, they will know what to do, after their positive experience with our treatment for vitiligo before. 

They will just have too undergo the same treatment again. But we still hope their vitiligo will not come back again.

Chapter B: 

Some remarks about orthomolecular medicine, which is the main objective of treatment in our clinic.

In our clinic we practice orthomolecular medicine.

This medical approach uses essential nutrients like vitamins, trace elements, minerals, amino acids and essential fatty acids and other essential nutrients for treatment, mainly in considerably higher dose compared to its contents in food.

One aim of our treatment is to compensate objective deficits in these essential nutrients.

For this purpose usually lower doses of supplements are sufficient.

For therapeutic use in order to fight acute or chronic ill conditions, we will use much higher concentrations of these supplements.  We will do this even in cases, where there is no objective deficit of any of these supplements found by laboratory tests in the blood of the patient.

It is very important to understand the difference between a simple supplementation in order to compensate deficits of essential nutrients (low dose supplementation) with preventive intentions on one side and the therapeutic use of much higher dose for treatment of existing ill conditions on the other side.

The first objective is well recognized by mainstream medicine, the second one, the therapeutic use in high concentrations, is not recognized by mainstream medicine.

In orthomoleculare medicine we use our knowledge about modern biochemistry and physiology, which includes the knowledge about the role of vitamins, trace elements, minerals, amino acids and essential fatty acids and other essential nutrients in our metabolic system.

With higher dose of specific substances we may enhance (support) a specific metabolic pathway which is dependent on these specific substances.

Two examples for this approach (in this case in the treatment of vitiligo) are given on this home page (please refer to our German part of this homepage “Therapie” and then “Biochemie!)

In most of the cases our specific prescriptions are covered by clinical research (for clinical research on vitiligo, please refer to “Thertapie” and “Studien” in the German part of this homepage (Studies mixed in German and in English).

If clinical research is not existent in some cases, we use our basic knowledge about the biochemical effects of these substances that we consider for treatment in order to boost or enhance this specific biochemical pathways which may play a role in a given ill condition.

The advantage of orthomolecular medicine is that, by the nature of the substances which we use for treatment, we will not have too consider side-effects.  The reason is, that all these orthomolecular therapeutics are a natural part of our metabolic system, which means, our metabolic system knows how to handle them, in contrast to the artificially produced pharmaceuticals in the laboratories of the pharmaceutical industry, which are foreign to our metabolic systems and for this must be named what they are: they are poisons.

The only reason, why we can sometimes accept this poisonous nature of these pharmaceutical xenobiotics is, that, at best, their beneficial effects are evaluated higher then their poisonous effect on our metabolic system.

The reason why orthomolecular medicine is still not recognized by mainstream medicine is simple in my own personal opinion: orthomolecular medicine is not profitable for the pharmaceutical industry.  Just contrarily, orthomolecular medicine, if it would be better known by doctors and patients, would produce a great loss in financial benefit by the pharmaceutical industry, because it would make a great amount of pharmaceuticals unnecessary for many patients.

If the pharmaceutical industry sometimes argues, that there is not enough research on the benefits of orthomolecular medicine, firstly this is not true in most of the cases, secondly, if this is true, the reason for this deficit lies in the fact, that the pharmaceutical industry can invest millions and billions in the research of their products, because after obtaining a patent on their pharmaceutical drug, they can easily recover their investment in research of these drugs.  This is not the case for substances which are used in orthomolecular medicine, because nobody can ever obtain a patent on natural substances, like they are used in orthomolecular medicine (orphan drugs).  The investment on research in “orphan drugs” would never be recovered. So research on orthomolecular supplements are present and available, but most of the time the number of patients used in this clinical research may be much less (30, 50, 100, 600 patients) compared to some research performed by the pharmaceutical industry (500, 1000, 10 000 patients), and because of the costs involved by studying higher numbers of patients.

So don't be fooled, when anybody around you, even doctors and scientists sometimes argue, orthomolecular medicine is not proven.  It is well proven and effective.  But the pharmaceutical industry and the mainstream doctors who are depending on it, just don't like it.